Global Biobanking Summit 2014

Biobanking will grow by 30% by 2020, will yours grow with it?

With Biobanking becoming increasingly important with the rise of biologic and personalised medicine making sure you can get the most out of your samples is key.

The conference will allow you to Understand cross border regulatory requirements, the impact of the pending EU regulations, consent, efficient storage and tracking strategies to ensure quality will allow you to move forward with your research and improve your drug discovery process.

Early confirmed 2014 speakers
Rachel Mager
Global Head of Biobanking
Astra Zeneca

Andy Zaayenga
president
ISBER

James Brennan
IT maanger
Uk Biobank

and many more...